Use of transgenic mice reveals cell-specific transformation by a simian virus 40 T-antigen amino-terminal mutant.
Open Access
- 1 June 1993
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 13 (6) , 3255-3265
- https://doi.org/10.1128/mcb.13.6.3255
Abstract
We have used the multifunctional transforming protein, simian virus 40 T antigen, as a probe to study the mechanisms of cell growth regulation in the intact organism. T antigen appears to perturb cell growth, at least in part, by stably interacting with specific cellular proteins that function to maintain normal cell growth properties. Experiments in cultured cells indicate that at least three distinct regions of simian virus 40 T antigen have roles in transformation. Two regions correlate with the binding of known cellular proteins, p53, pRB, and p107. A third activity, located near the amino terminus, has been defined genetically but not biochemically. By targeting expression of wild-type and mutant forms of T antigen to distinct cell types in transgenic mice, we have begun to systematically determine which activities play a role in tumorigenesis of each cell type. In this study, we sought to determine the role of the amino-terminal transformation function with such an analysis of the T-antigen mutant dl1135. This protein, which lacks amino acids 17 to 27, retains the p53-, pRB-, and p107-binding activities yet fails to transform cells in culture. To direct expression in transgenic mice, we used the lymphotropic papovavirus transcriptional signals that are specific for B and T lymphocytes and the choroid plexus epithelium of the brain. We show here that although defective in cell culture, dl1135 specifically induced the development of thymic lymphomas in the mouse. Expression of the protein was routinely observed in B- and T-lymphoid cells, although B-cell abnormalities were not observed. Choroid plexus tumors were observed only infrequently; however, dl1135 was not consistently expressed in this tissue. Within a given transgenic line, the penetrance of T-cell tumorigenesis was 100% but appeared to require secondary events, as judged from the clonal nature of the tumors. These experiments suggest that the amino-terminal region of T antigen has a role in the transformation of certain cell types (such as fibroblasts in culture and B lymphocytes) but is dispensable for the transformation of T lymphocytes.Keywords
This publication has 38 references indexed in Scilit:
- Lymphocyte Development from Stem CellsAnnual Review of Immunology, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related proteinCell, 1991
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- Transgenic models for haemopoietic malignanciesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1991
- Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene productsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
- Disruption of thymocyte development and lymphomagenesis induced by SV4O T-antigenInternational Immunology, 1990
- The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large TCell, 1990
- When the products of oncogenes and anti-oncogenes meetCell, 1989
- A monoclonal antibody that recognizes B cells and B cell precursors in mice.The Journal of Experimental Medicine, 1981